Filing Details
- Accession Number:
- 0000950170-25-088105
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-06-18 21:16:04
- Reporting Period:
- 2025-06-16
- Filing Date:
- 2025-06-18
- Accepted Time:
- 2025-06-18 21:16:04
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1579428 | Axsome Therapeutics Inc. | AXSM | Pharmaceutical Preparations (2834) | 454241907 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1934008 | R. Hunter Murdock | C/O Axsome Therapeutics, Inc. One World Trade Center, 29Th Floor New York NY 10007 | General Counsel | No | No | No | No |
Transaction Summary
| Sold: | 22,500 shares | Avg. Price: $101.19 | Total Value: $2,276,850.00 |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-06-16 | 7,500 | $29.91 | 7,500 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2025-06-16 | 7,500 | $102.42 | 0 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2025-06-17 | 7,500 | $29.91 | 7,500 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2025-06-17 | 7,500 | $100.26 | 0 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2025-06-18 | 7,500 | $29.91 | 7,500 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2025-06-18 | 7,500 | $100.90 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2025-06-16 | 7,500 | $0.00 | 7,500 | $29.91 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2025-06-17 | 7,500 | $0.00 | 7,500 | $29.91 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2025-06-18 | 7,500 | $0.00 | 7,500 | $29.91 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 44,883 | 2023-03-04 | 2032-03-04 | No | 4 | M | Direct |
| 37,383 | 2023-03-04 | 2032-03-04 | No | 4 | M | Direct |
| 29,883 | 2023-03-04 | 2032-03-04 | No | 4 | M | Direct |
Footnotes
- Such transaction was pursuant to a pre-approved 10b5-1 plan.
- Represents the subsequent sale of the underlying shares of the aforementioned exercise of stock options.
- Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $101.01 and $104.09
- Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $100.00 and $101.53.
- Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $100.00 and $101.96.
Billionaire Hedge Funds
